Price

Zacks Small Cap Research – SDA: SunCar Technology Group’s Growth Potential Supports Price Target of $20.00. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:SDA READ THE FULL SDA RESEARCH REPORT Company Announces New Chief Strategy Officer On January 13, 2025, the SunCar (NASDAQ:SDA) announced that Breaux Walker was appointed Chief Strategy Officer. Mr. Walker will oversee the company’s capital markets strategy, investments, international financing, and investor relations. Mr. Walker has over 25 years of … Read more

Vanguard price rise: what’s the impact and what are the alternatives? – Go Health Pro

by
Vanguard price rise: what’s the impact and what are the alternatives? – Go Health Pro

It looks like Vanguard is no longer the undisputed consumer champion of old. Vanguard’s USP has been waning for a while but the recent announcement of a £4 per month minimum charge for DIY investment services has put the tin lid on it.  Previously, Vanguard’s DIY investors paid a 0.15% platform fee calculated on their … Read more

Progressive looks to reduce price further for $345m Bonanza Re 2024-1 cat bond – Go Health Pro

by
Progressive looks to reduce price further for 5m Bonanza Re 2024-1 cat bond – Go Health Pro

US insurance firm Progressive is targeting even more favourable price execution for its latest venture to the catastrophe bond market, with the spread guidance for its new $345 million Bonanza Re Ltd. (Series 2024-1) issuance having fallen further in the latest update, we understand.Progressive returned to the cat bond market in late November, with what … Read more

2025 Housing Price Forecasts: Continued Strong Gains – Go Health Pro

by
2025 Housing Price Forecasts: Continued Strong Gains – Go Health Pro

Now that I’ve shared the 2025 S&P 500 target price forecast, let’s dive into housing price forecasts for 2025. The outlook from housing analysts is positive, with expected gains ranging from -0.4% to 10.8%, and an average of about 3%. The only negative housing price forecast comes from Moody’s, which predicts a slight decline of -0.4% largely … Read more

Zacks Small Cap Research – MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 3rd quarter 2024 financial results on November 14th which were largely in line with expectations. Research and development expenses for the quarter ending September 30, 2024 were $2.2 million compared to $2.7 million in the prior year period. The R&D decrease … Read more

x